Search Within

Michael J Zelefsky

Formats
  1. Journal Article (421)
  2. Meeting Abstract (266)
  3. Book Section (45)
  4. Conference Paper (11)
  5. Book Whole (3)
  6. Review (3)
  7. Correspondence (2)
  8. Editorial (2)
  9. Guidelines (1)
Groups
  1. Survivorship Research (754)
  2. Radiation Oncology, Department of (324)
  3. Medical Physics (278)
  4. Radiotherapy Physics Service (204)
  5. GDMT, Radiation Oncology (187)
  6. Gynecology Disease Management Team (187)

More Groups

People
  1. Marisa Kollmeier (152)
  2. Zvi Fuks (117)
  3. Steven Leibel (112)
  4. Yoshiya Yamada (98)
  5. Gilad Cohen (84)
  6. Zhigang Zhang (80)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (17)
  4. 2022 (19)
  5. 2021 (28)
  6. 2020 (13)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (319)
  2. Brachytherapy (46)
  3. Journal of Clinical Oncology (40)
  4. Radiotherapy and Oncology (34)
  5. Medical Physics (23)
  6. European Urology (16)

More Publications

Publishers
  1. Elsevier Inc. (401)
  2. Elsevier Science, Inc. (98)
  3. American Society of Clinical Oncology (41)
  4. Wiley Blackwell (25)
  5. American Association of Physicists in Medicine (23)
  6. Lippincott Williams & Wilkins (15)

More Publishers

Results (754)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • External beam radiotherapy for small cell carcinoma of the urinary bladder: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Kollmeier, M.; Kan, C. C.; Bochner, B.; Dalbagni, G.; Bajorin, D. F.; Zelefsky, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A dosimetric analysis of prostate cancer treatment: Can SBRT really achieve what HDR can?
    Meeting Abstract

    Spratt, D. E.; Scala, M.; Cohen, G. N.; Happersett, L.; Zelefsky, M. J.; Kollmeier, M.; Cox, B.; Yamada, Y.
    Radiotherapy and Oncology (2012)

    Fulltext@MSK | Save
  • V150 predicts erectile outcome in patients undergoing low-dose-rate (LDR) brachytherapy alone for prostate cancer
    Meeting Abstract

    Kollmeier, M. A.; Scala, L. M.; Kunaprayoon, D.; Mathur, N.; Cohen, G.; Pei, X.; Zhang, Z.; Mulhall, J.; Cox, B.; Zelefsky, M. J.
    Radiotherapy and Oncology (2012)

    Fulltext@MSK | Save
  • Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer
    Meeting Abstract

    Cuaron, J.; Pei, X.; Cohen, G.; Cox, B.; Yamada, Y.; Zelefsky, M.; Kollmeier, M.
    Radiotherapy and Oncology (2012)

    Fulltext@MSK | Save
  • How to select the optimal therapy for early-stage prostate cancer
    Journal Article

    Kollmeier, M. A.; Zelefsky, M. J.
    Critical Reviews in Oncology/Hematology (2012)

    Fulltext@MSK | Save
  • Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
    Journal Article

    Zelefsky, M. J.; Kollmeier, M.; Cox, B.; Fidaleo, A.; Sperling, D.; Pei, X.; Carver, B.; Coleman, J.; Lovelock, M.; Hunt, M.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Short-term androgen deprivation decreases distant metastasis and prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose escalated external beam radiation therapy
    Meeting Abstract

    Zumsteg, Z. S.; Spratt, D. E.; Pei, X.; Yamada, Y.; Kalikstein, A.; Kuk, D.; Zhang, Z.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Results of a prospective randomized double-blind, placebo-controlled trial evaluating the use of prophylactic sildenafil citrate during radiation therapy in the treatment of prostate cancer
    Meeting Abstract

    Zelefsky, M. J.; Shasha, D.; Kollmeier, M.; Baser, R. E.; Cox, B.; Stock, R.; Ennis, R. D.; Bar-Chama, N.; Pei, X.; Mulhall, J.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Metformin improves prostate cancer-specific survival and inhibits the development of castrate resistant metastasis
    Meeting Abstract

    Spratt, D.; Zhang, C.; Zumsteg, Z. S.; Pei, X.; Zhang, Z.; Yamada, J.; Kollmeier, M.; Cox, B.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Long-term survival and toxicity of patients treated with ultra-high-dose IMRT for localized prostate cancer
    Meeting Abstract

    Spratt, D.; Pei, X.; Yamada, J.; Kollmeier, M. A.; Cox, B.; Zhang, Z.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save